CHLORPROTHIXENE

SynDRA canonical compound SYN0002513 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	CHRM1 \| CHRM2 \| CHRM3 \| CHRM4 \| CHRM5 \| DRD1 \| DRD2 \| DRD3 \| HRH1 \| HTR2A \| HTR2B \| HTR2C
Mechanism of action	dopamine receptor antagonist
Indication	bipolar disorder \| schizophrenia
Disease area	neurology/psychiatry

All known targets

DRD2
DRD3
HTR2A
CHRM2
CHRM3
CHRM4
CHRM5
DRD1
CHRM1
HRH1
HTR2C
ABCG2

Mechanisms of action (all sources)

DRD2 ANTAGONIST
Dopamine D2 receptor antagonist
DRD3 ANTAGONIST
Dopamine D3 receptor antagonist
HTR2A ANTAGONIST
Serotonin 2a (5-HT2a) receptor antagonist
HTR2C ANTAGONIST
Serotonin 2c (5-HT2c) receptor antagonist
dopamine receptor antagonist

Drug classes

Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Neurotransmitter Agents
Psychotropic Drugs
Tranquilizing Agents

ATC classes

N05A · ANTIPSYCHOTICS

Cross-references

PubChem CID: 667467
ChEMBL: CHEMBL908
DrugBank: DB01239
ChEBI: CHEBI:3651
KEGG: D00790
Wikipedia: Chlorprothixene
TTD: D0B0CP

Synonyms

Look up CHLORPROTHIXENE in the interactive SynDRA portal →